Title of article :
Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability
Author/Authors :
Gaël G. McGill، نويسنده , , Martin Horstmann، نويسنده , , Hans R. Widlund، نويسنده , , Jinyan Du، نويسنده , , Gabriela Motyckova، نويسنده , , Emi K. Nishimura، نويسنده , , Yiling Lin، نويسنده , , Sridhar Ramaswamy، نويسنده , , William Avery، نويسنده , , Han-Fei Ding، نويسنده , , Siobh?n A. Jordan، نويسنده , , Ian J. Jackson، نويسنده , , Stanley J. Korsmeyer، نويسنده , , Todd R. Golub، نويسنده , , David E. Fisher، نويسنده ,
Issue Information :
هفته نامه با شماره پیاپی سال 2002
Pages :
12
From page :
707
To page :
718
Abstract :
Kit/SCF signaling and Mitf-dependent transcription are both essential for melanocyte development and pigmentation. To identify Mitf-dependent Kit transcriptional targets in primary melanocytes, microarray studies were undertaken. Among identified targets was BCL2, whose germline deletion produces melanocyte loss and which exhibited phenotypic synergy with Mitf in mice. BCL2ʹs regulation by Mitf was verified in melanocytes and melanoma cells and by chromatin immunoprecipitation of the BCL2 promoter. Mitf also regulates BCL2 in osteoclasts, and both Mitfmi/mi and Bcl2−/− mice exhibit severe osteopetrosis. Disruption of Mitf in melanocytes or melanoma triggered profound apoptosis susceptible to rescue by BCL2 overexpression. Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. This linkage helps explain the vital roles of both Mitf and Bcl2 in the melanocyte lineage and the well-known treatment resistance of melanoma.
Journal title :
CELL
Serial Year :
2002
Journal title :
CELL
Record number :
1017842
Link To Document :
بازگشت